We evaluated the prognostic role of metabolic syndrome after myocardial infarction and found that metabolic syndrome correlated with an increased risk of cardiovascular events and death. The risk of developing diabetes decreased with weight loss in patients with metabolic syndrome. These results indicate that a more aggressive approach to the treatment of patients with metabolic syndrome, particularly with regard to changes in lifestyle, would be beneficial.
The PA profession has grown nearly 54% in 7 years, particularly in specialties including surgery, emergency medicine, dermatology, and hospital medicine.
Experts look into what is next for sickle cell disease and provide key thoughts on the space.
Expert providers in inflammatory diseases provide additional resources on biosimilars and adalimumab biosimilar for patients and providers.
Marc P. Bonaca, MD, MPH, of the University of Colorado School of Medicine, comments on the potential to personalize treatment with emerging therapies in the pipeline to better manage patients at high risk for cardiovascular disease in the future.
Expert endocrinologists provide final thoughts on addressing unmet needs and improving the management of T1D.
Iltefat Hamzavi, MD, explores key areas of patient communication that may shape adherence and outcomes in patients with vitiligo.
Trigger avoidance-only strategies don’t actually help migraine patients improve. These are the proactive behaviors that do.
A variety of online drowning prevention resources can be accessed by parents and health care professionals, promoting safe swimming in the summer.
Drs Erin Michos, Pam Taub, Robert Busch, Alison Bailey, and Jorge Plutzky offer key takeaways in the management of hypercholesterolemia and ASCVD.
If approved, the treatment would be the first SGLT2 inhibitor for patients with chronic kidney disease.
Closing their discussion on insomnia, panelists share final thoughts and advice for community physicians.
Closing out their discussion on the management of atopic dermatitis, expert panelists share clinical pearls and key takeaways from their discussion.
Dr Andrew Cutler and Dr Greg Mattingly review current understanding of anhedonia. They discuss how clinicians can better evaluate it by effectively and candidly communicating with patients about anhedonia.
Brad Glick, DO, MPH; Mona Shahriari, MD, FAAD; Michael Cameron, MD, FAAD; and Linda Stein Gold, MD, comment on the future of plaque psoriasis treatment and share clinical pearls on the management of plaque psoriasis.
Experts in gastroenterology discuss treatment selection in special situations of CD, such as age, women considering pregnancy, and extra-intestinal manifestations.
Hanita Chhabra, MD, highlights safety and efficacy data of esketamine and shares practical implications for clinical practice.
Expert hepatologists discuss future developments in HCV that they are excited about and provide resources for new providers to get started on delivering HCV care.
Proton beam therapy has been heavily adopted for treating patients with nasopharyngeal cancer, and a high incidence of severe ARD has been reported in this patient population.
Gina Mangin, MPAS, PA-C, shares take-home pearls with fellow healthcare providers, highlighting the importance of listening to the patient.
Closing thoughts on advice to community pediatricians evaluating a baby for spinal muscular atrophy (SMA).
Expert endocrinologists provide final thoughts on addressing unmet needs and improving the management of T1D.
Panelists discuss potential biomarkers and clinical indicators that can aid in predicting disease outcomes for individual patients with IgA nephropathy.